Listonstreetpulse.com announces that Arrayit Corporation (OTC: ARYC), a developer, manufacturer and marketer of proprietary life science technologies and consumables for disease prevention, treatment and cure, is seeking a commercialization partner in Israel in order to expand the use of its patented Variation Identification Platform (VIP) DNA testing technology. The technology is covered by Israeli Patent Number 153848. The patent has empowered ARYC to develop and commercialize economical DNA screening tests to identify sequence variants in the human genome that predispose individuals to cancer, diabetes, Crohn’s and Tay-Sachs Disease and other medical conditions.
In assistance with a doctor, Arrayit genetic testing can inform lifestyle, dietary and therapeutic improvements to ensure greater health and well-being. ARYC testing can also recognize carriers of genetic disorders to enable married couple to make better informed family decisions. The company’s patented technology in Israel uses microarray devices, which include thousands of patient DNA samples to recognize single nucleotide polymorphisms (SNPs) in the genetic code that alter the function of cellular genes.
The capacity to test thousands of patients at once instead of one patient at a time offers improved testing speed, accuracy and healthcare cost reductions. ARYC sees these as key strategic market advantages for its technology.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
###
